Status:
COMPLETED
Validation of Laser Doppler Vibrometer (LDV) for Measurement of Arterial Stiffness in Hypertensive Patients
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Hypertension
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The aim is to compare a new technique for assessing local and regional arterial stiffness: the Laser Doppler Vibrometry with the reference techniques, the applanation tonometry and echotracking.
Detailed Description
Cardiovascular (CV) diseases and their risk factors are the major contributors to global morbidity and mortality. CV diseases are responsible for over 17.3 million deaths per year worldwide, represent...
Eligibility Criteria
Inclusion
- Patients with grade I-III essential arterial hypertension, recently diagnosed, well controlled or insufficiently equilibrated under stable antihypertensive treatment for their HTA
Exclusion
- Severe pathologies interfering with HTA or not allowing measurement by the techniques of interest, including skin diseases impeding the applanation tonometry
- Allergies to ultrasound gel or to adhesive film
Key Trial Info
Start Date :
June 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03446430
Start Date
June 21 2018
End Date
December 4 2018
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Européen Georges Pompidou / Service de Pharmacologie
Paris, France, 75015